Anthony @ Equity Investigations, Dear Anthony, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: StockDung	1/27/2017 1:36:12 PM
	of 122088

Crooked Ray Dirks is back. Seems to have left off the massive frauds he was involved in his resume see: Subject 52930 ==================================== Dirks Is Back Ray Dirks is back - introducing his new website News provided by RAY DIRKS RESEARCH Dec 22, 2016, 08:00 ET NEW YORK, Dec. 22, 2016 /PRNewswire/ -- RAY DIRKS RESEARCH, available early 2017. His stock market views will be on this site. Dirks is very bullish now. Career highlights of Ray Dirks: Joined Goldman Sachs in 1963 as first Insurance Analyst with major firm. Headed 500-employee investment banking firm. Raised billions through managing hundreds of Initial Public Offerings in the 70's-80's. Dirks unearthed massive Equity Funding insurance stock fraud in 1973, largest stock fraud until Enron. In 1983 Dirks won against the SEC in supreme court. Dirks vs SEC defined 'insider trading' and is taught in law schools. Following are some samples of the types of coverage Dirks Research intends to provide. INSURANCE Hartford Financial Services Group and Aflac Incorporated. Hartford, the oldest US property casualty insurance company is one of the largest in the world. Book value is considerably higher than stock price. Additionally, substantial reinsurance protects it's downside risk. Aflac of Columbus, Georgia is the fastest growing health/life Insurance company in Japan. Yes, it is the same company with the duck! Aflac markets through its own agency and a vast network of Japanese post offices. It has high dividends and a strong history of stock buyback. Current P/E of 11 is roughly 50% of the last 30 years. HEALTHCARE Speaking of Japan, Cyberdyne is in the news recently. This neurorobotics company has modest sales, no earnings and nearly $2 billion market cap. Japanese are betting heavily on neurorobotics which allow the brain, or weak muscles to provide inputs to aid disabled limbs to function. Their history of nursing obscure technology to commercial blockbusters is enviable. Remember the VCR? Bionik Laboratories is similar but with better technology. MIT professors Drs. Hogan and Krebs, pioneers of neurorobotics are with Bionik. BNKL has several FDA approved products to rehabilitate stroke victims with paralysis which are ready to be marketed. The annual 400,000 impaired stroke victims should benefit from Bionik neurorobotics in 2017. Bionik robotics will be essential component of the $15 billion US physiotherapy market soon. Contact: Raydirksresearch@gmail.com 1-917-443-1892 To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/dirks-is-back-300382992.html SOURCE RAY DIRKS RESEARCH

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next